Literature DB >> 2895591

Vector potential of selected North American mosquito species for Rift Valley fever virus.

T P Gargan1, G G Clark, D J Dohm, M J Turell, C L Bailey.   

Abstract

Selected North American mosquito species were evaluated as potential vectors of Rift Valley fever virus. Field populations of Aedes canadensis, Ae. cantator, Ae. excrucians, Ae. sollicitans, Ae. taeniorhynchus, Ae. triseriatus, Anopheles bradleyi-crucians, Culex salinarius, Cx. tarsalis, and Cx. territans perorally exposed to 10(6.2)-10(7.2) plaque forming units of Rift Valley fever virus readily became infected. Infection rates ranged from 51% (65/127) for Cx. salinarius to 96% (64/67) for Ae. canadensis. Disseminated infection rates were generally greater at 14 days than at 7 days after the infectious bloodmeal, and, with the exception of An. bradleyi-crucians, they were not significantly different than the pooled rate of 59% for each species tested. Only 5/55 (9%) of the An. bradleyi-crucians developed a disseminated infection. For most of the species, about half of the mosquitoes with a disseminated infection transmitted an infectious dose of virus to hamsters. While all species, with the exception of An. bradleyi-crucians, transmitted virus, Ae. canadensis, Ae. taeniorhynchus, and Cx. tarsalis had the highest vector potential of the species tested. Following inoculation of approximately 10(1.6) plaque forming units of virus, 100% of the mosquitoes of each species became infected. For most species, transmission rates were similar for inoculated individuals and those that developed a disseminated infection following peroral infection. Viral titers of transmitting and nontransmitting-disseminated individuals were similar for all species tested. These data suggest that, if Rift Valley fever virus was introduced into North America, several mosquito species would be capable of transmitting it.

Entities:  

Mesh:

Year:  1988        PMID: 2895591     DOI: 10.4269/ajtmh.1988.38.440

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  34 in total

1.  Genetic reassortment of Rift Valley fever virus in nature.

Authors:  A A Sall; P M Zanotto; O K Sene; H G Zeller; J P Digoutte; Y Thiongane; M Bouloy
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  Characterization of the Golgi retention motif of Rift Valley fever virus G(N) glycoprotein.

Authors:  Sonja R Gerrard; Stuart T Nichol
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  Mechanism of tripartite RNA genome packaging in Rift Valley fever virus.

Authors:  Kaori Terasaki; Shin Murakami; Kumari G Lokugamage; Shinji Makino
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

4.  Rift Valley fever virus structural and nonstructural proteins: recombinant protein expression and immunoreactivity against antisera from sheep.

Authors:  Bonto Faburay; William Wilson; D Scott McVey; Barbara S Drolet; Hana Weingartl; Daniel Madden; Alan Young; Wenjun Ma; Juergen A Richt
Journal:  Vector Borne Zoonotic Dis       Date:  2013-08-20       Impact factor: 2.133

Review 5.  A review of mosquitoes associated with Rift Valley fever virus in Madagascar.

Authors:  Luciano M Tantely; Sébastien Boyer; Didier Fontenille
Journal:  Am J Trop Med Hyg       Date:  2015-03-02       Impact factor: 2.345

6.  The C-terminal region of Rift Valley fever virus NSm protein targets the protein to the mitochondrial outer membrane and exerts antiapoptotic function.

Authors:  Kaori Terasaki; Sungyong Won; Shinji Makino
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

7.  Crystal structure of glycoprotein C from Rift Valley fever virus.

Authors:  Moshe Dessau; Yorgo Modis
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-14       Impact factor: 11.205

8.  Rift Valley fever virus epidemic in Kenya, 2006/2007: the entomologic investigations.

Authors:  Rosemary Sang; Elizabeth Kioko; Joel Lutomiah; Marion Warigia; Caroline Ochieng; Monica O'Guinn; John S Lee; Hellen Koka; Marvin Godsey; David Hoel; Hanafi Hanafi; Barry Miller; David Schnabel; Robert F Breiman; Jason Richardson
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

9.  Rift Valley fever virus(Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention.

Authors:  Michel Pepin; Michele Bouloy; Brian H Bird; Alan Kemp; Janusz Paweska
Journal:  Vet Res       Date:  2010 Nov-Dec       Impact factor: 3.683

10.  NSm protein of Rift Valley fever virus suppresses virus-induced apoptosis.

Authors:  Sungyong Won; Tetsuro Ikegami; C J Peters; Shinji Makino
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.